Insulin or Dapagliflozin Potentially Improves Microcirculatory Dysfunction or INOCA Related to Culprit Vessels in Diabetic Patients With STEMI After DCB Therapy During Long‐Term Follow‐Up

Documenti analoghi

• Paeonol Improves Cardiac Remodelling in MI Mice by Suppressing NOX2 mRNA Expression to Mitigate Oxidative Stress and Mitochondrial Dysfunction
  di: Yun Liu, et al.
  Pubblicazione: (2025)
• Correction to “Long‐Term Outcomes of DCB and DES for the Treatment of In‐Stent Restenosis in Relation to the Vessel Size”
  Pubblicazione: (2025)
• Machine Learning‐Assisted Analysis of Sublingual Microcirculatory Dysfunction for Early Cardiovascular Risk Evaluation and Cardiovascular‐Kidney‐Metabolic Syndrome Stage in Patients With Type 2 Diabetes Mellitus
  di: Wei Liu, et al.
  Pubblicazione: (2024)
• Metformin Use Reduces the Risk of Olfactory Dysfunction in Diabetic Patients: A 22‐Year Follow‐Up Study
  di: Yu‐Chun Chen, et al.
  Pubblicazione: (2025)
• Choroidal Microcirculatory Responses to Hemodialysis in Patients With Diabetic Nephropathy and Retinopathy
  di: Ryuya Hashimoto, et al.
  Pubblicazione: (2026)